UnitedHealth Group Incorporated $UNH Stock Holdings Increased by Galvin Gaustad & Stein LLC

Galvin Gaustad & Stein LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 35.5% during the second quarter, Holdings Channel reports. The firm owned 78,913 shares of the healthcare conglomerate’s stock after purchasing an additional 20,688 shares during the period. UnitedHealth Group makes up 2.1% of Galvin Gaustad & Stein LLC’s portfolio, making the stock its 11th largest holding. Galvin Gaustad & Stein LLC’s holdings in UnitedHealth Group were worth $24,618,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Citizens National Bank Trust Department increased its position in shares of UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH increased its position in shares of UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC increased its position in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management purchased a new position in UnitedHealth Group during the second quarter valued at approximately $1,324,000. Finally, Wealth Effects LLC grew its position in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the topic of a number of research analyst reports. Sanford C. Bernstein boosted their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research report on Wednesday. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Oppenheimer lowered their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday. Finally, Robert W. Baird reiterated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $367.69 on Friday. The firm has a fifty day simple moving average of $315.87 and a 200-day simple moving average of $351.51. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market capitalization of $333.01 billion, a price-to-earnings ratio of 15.93, a PEG ratio of 2.39 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.